Wen Z, Li W, Shi C, Ma J, Zhao S, Zhou R, et al. Genetic and immunologic characteristics of colorectal cancer patients with KRAS mutations and predictive significance of tumor immune microenvironment in adjuvant chemotherapy. Genes Dis. 2023;11:100983.

Article  PubMed  PubMed Central  Google Scholar 

Liu C, Xiao H, Cui L, Fang L, Han S, Ruan Y, et al. Epigenetic-related gene mutations serve as potential biomarkers for immune checkpoint inhibitors in microsatellite-stable colorectal cancer. Front Immunol. 2022;13:1039631.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fadlallah H, El Masri J, Fakhereddine H, Youssef J, Chemaly C, Doughan S, et al. Colorectal cancer: Recent advances in management and treatment. World J Clin Oncol. 2024;15:1136–56.

Article  PubMed  PubMed Central  Google Scholar 

Roshandel G, Ghasemi-Kebria F, Malekzadeh R. Colorectal cancer: epidemiology, risk factors, and prevention. Cancers (Basel). 2024;16(8):1530.

Article  PubMed  Google Scholar 

Tian J, Zhang M, Zhang F, Gao K, Lu Z, Cai Y, et al. Developing an optimal stratification model for colorectal cancer screening and reducing racial disparities in multi-center population-based studies. Genome Med. 2024;16:81.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Atchade AM, Williams JL, Mermelstein L, Nemesure B. Unraveling the complexities of early-onset colorectal cancer: a perspective on dietary and microbial influences. Front Public Health. 2024;12:1370108.

Article  PubMed  PubMed Central  Google Scholar 

Loroña NC, Himbert C, Ose J, Cohen SA, Strehli I, Ulrich CM, et al. Alcohol consumption and smoking history at the time of diagnosis and the risk of colorectal cancer recurrence and mortality: results from the colocare study. Cancer Epidemiol Biomarkers Prev. 2025;34:59–66.

Article  PubMed  Google Scholar 

Fusco W, Bricca L, Kaitsas F, Tartaglia MF, Venturini I, Rugge M, et al. Gut microbiota in colorectal cancer: From pathogenesis to clinic. Best Pract Res Clin Gastroenterol. 2024;72:101941.

Article  PubMed  Google Scholar 

Jiang M, Zhang X, Huang H, Sun G, Huang Y, Chen Y. A Novel four-gene biomarker for tobacco smoking-induced colorectal cancer progression. Nicotine Tob Res. 2024;26(10):1286–95.

Article  CAS  PubMed  Google Scholar 

Jiang J, Meng X, Wang Y, Zhuang Z, Du T, Yan J. Effect of aberrant fructose metabolism following SARS-CoV-2 infection on colorectal cancer patients’ poor prognosis. PLoS Comput Biol. 2024;20:e1012412.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bakillah E, Sharpe J, Wirtalla C, Goldberg D, Altieri MS, Aarons CB, et al. Minimally invasive colorectal cancer surgery: an observational study of medicare advantage and fee-for-service beneficiaries. Surg Endosc. 2024;38:6800–11.

Article  PubMed  PubMed Central  Google Scholar 

Lahouty M, Fadaee M, Shanehbandi D, Kazemi T. Exosome-driven nano-immunotherapy: revolutionizing colorectal cancer treatment. Mol Biol Rep. 2024;52:83.

Article  PubMed  Google Scholar 

Brockmueller A, Sajeev A, Koklesova L, Samuel SM, Kubatka P, Büsselberg D, et al. Resveratrol as sensitizer in colorectal cancer plasticity. Cancer Metastasis Rev. 2024;43:55–85.

Article  CAS  PubMed  Google Scholar 

Manz SM, Losa M, Fritsch R, Scharl M. Efficacy and side effects of immune checkpoint inhibitors in the treatment of colorectal cancer. Therap Adv Gastroenterol. 2021;14:17562848211002018.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abedizadeh R, Majidi F, Khorasani HR, Abedi H, Sabour D. Colorectal cancer: a comprehensive review of carcinogenesis, diagnosis, and novel strategies for classified treatments. Cancer Metastasis Rev. 2024;43:729–53.

Article  PubMed  Google Scholar 

Chung SS, Dutta P, Austin D, Wang P, Awad A, Vadgama JV. Combination of resveratrol and 5-flurouracil enhanced anti-telomerase activity and apoptosis by inhibiting STAT3 and Akt signaling pathways in human colorectal cancer cells. Oncotarget. 2018;9:32943–57.

Article  PubMed  PubMed Central  Google Scholar 

Gallois C, Bergen ES, Auclin É, Pernot S, Higué J, Trouilloud I, et al. Efficacy and safety of the combination of encorafenib/cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: an AGEO real-world multicenter study. ESMO Open. 2024;9:103696.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ahn DH, Ridinger M, Cannon TL, Mendelsohn L, Starr JS, Hubbard JM, Kasi A, Barzi A, Samuëlsz E, Karki A, Subramanian RA. Onvansertib in combination with chemotherapy and bevacizumab in second-line treatment of kras-mutant metastatic colorectal cancer: a single-arm, Phase II Trial. J Clinic Oncol. 2025;43(7):840–51.

Article  CAS  Google Scholar 

Han R, Ma L, Terzaghi W, Guo Y, Li J. Molecular mechanisms underlying coordinated responses of plants to shade and environmental stresses. Plant J. 2024;117:1893–913.

Article  CAS  PubMed  Google Scholar 

Zhou B, Yue JM. Terpenoids of plants from Chloranthaceae family: chemistry, bioactivity, and synthesis. Nat Prod Rep. 2024;41:1368–402.

CAS  PubMed  Google Scholar 

Muhammad SN, Ramli RR, Nik Mohamed Kamal NN, Fauzi AN. Terpenoids: Unlocking Their Potential on Cancer Glucose Metabolism. Phytotherapy Research. 2024 38(12):5626-40.

Sousa-Pimenta M, Estevinho LM, Szopa A, Basit M, Khan K, Armaghan M, et al. Chemotherapeutic properties and side-effects associated with the clinical practice of terpene alkaloids: paclitaxel, docetaxel, and cabazitaxel. Front Pharmacol. 2023;14:1157306.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang CH, Baskaran R, Ng SS, Wang TF, Li CC, Ho TJ, et al. Platycodin D confers oxaliplatin Resistance in Colorectal Cancer by activating the LATS2/YAP1 axis of the hippo signaling pathway. J Cancer. 2023;14:393–402.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang Y, Han J, Ma Y, Zhang J, Zhang Z, Wang G. Demethylzeylasteral inhibits cell proliferation and enhances cell chemosensitivity to 5-fluorouracil in Colorectal Cancer cells. J Cancer. 2020;11:6059–69.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Radenković N, Nikodijević D, Jovankić J, Blagojević S, Milutinović M. Resistance to 5-fluorouracil: The molecular mechanisms of development in colon cancer cells. Eur J Pharmacol. 2024;983:176979.

Article  PubMed  Google Scholar 

Bhattacharjya D, Sivalingam N. Mechanism of 5-fluorouracil induced resistance and role of piperine and curcumin as chemo-sensitizers in colon cancer. Naunyn Schmiedebergs Arch Pharmacol. 2024;397:8445–75.

Article  CAS  PubMed  Google Scholar 

Fan Z, Cui Y, Chen L, Liu P, Duan W. 23-Hydroxybetulinic acid attenuates 5-fluorouracil resistance of colorectal cancer by modulating M2 macrophage polarization via STAT6 signaling. Cancer Immunol Immunother. 2024;73:83.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bun SS, Elias R, Baghdikian B, Ciccolini J, Ollivier E, Balansard G. Alpha-hederin potentiates 5-FU antitumor activity in human colon adenocarcinoma cells. Phytother Res. 2008;22:1299–302.

Article  CAS  PubMed  Google Scholar 

Xia J, Dai QL, He S, Jia HJ, Liu XG, Hua H, et al. Artesunate alleviates 5-fluorouracil-induced intestinal damage by suppressing cellular senescence and enhances its antitumor activity. Discov Oncol. 2023;14:139.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Amerizadeh F, Rezaei N, Rahmani F, Hassanian SM, Moradi-Marjaneh R, Fiuji H, et al. Crocin synergistically enhances the antiproliferative activity of 5-flurouracil through Wnt/PI3K pathway in a mouse model of colitis-associated colorectal cancer. J Cell Biochem. 2018;119:10250–61.

Article  CAS  PubMed  Google Scholar 

Yang P, Liu W, Fu R, Ding GB, Amin S, Li Z. Cucurbitacin E